| 10106501 |
Nuclear receptor modulators |
Maria A. Argiriadi, Eric C. Breinlinger, Kevin P. Cusack, Adrian D. Hobson, Dominique Potin +4 more |
2018-10-23 |
$278,515,000 |
| 9751850 |
TRPA1 antagonists |
Richard J. Perner, Stanley DiDomenico, Jun Chen, Anil Vasudevan |
2017-09-05 |
$217,104,000 |
| 9156788 |
TRPV3 modulators |
Erol K. Bayburt, Bruce Clapham, Phil B. Cox, Jerome F. Daanen, Arthur Gomtsyan +2 more |
2015-10-13 |
$249,448,000 |
| 9108905 |
TRPA1 antagonists |
Richard J. Perner, Stanley DiDomenico, Jun Chen, Anil Vasudevan |
2015-08-18 |
$113,635,000 |
| 9012651 |
TRPV3 modulators |
Bruce Clapham, Phil B. Cox, Michael J. Dart, Arthur Gomtsyan, Tammie K. Jinkerson +7 more |
2015-04-21 |
$538,936,000 |
| 8969325 |
TRPV1 antagonists |
Michael J. Dart, Philip R. Kym, Eric A. Voight, Anurupa Shrestha, Jerome F. Daanen +7 more |
2015-03-03 |
$62,912,000 |
| 8877784 |
TRPA1 antagonists |
Richard J. Perner, Stanley DiDomenico, Jun Chen, Anil Vasudevan |
2014-11-04 |
$112,858,000 |
| 8859584 |
TRPV1 antagonists |
Kevin R. Woller, Gregory A. Gfesser, Huaqing Liu, Jerome F. Daanen, Eric A. Voight +5 more |
2014-10-14 |
$91,234,000 |
| 8802711 |
TRPV1 antagonists |
Arthur Gomtsyan, Jerome F. Daanen, Gregory A. Gfesser, Chih-Hung Lee, Heath A. McDonald +3 more |
2014-08-12 |
$78,239,000 |
| 8796328 |
TRPV1 antagonists |
Arthur Gomtsyan, Jerome F. Daanen, Philip R. Kym, Eric A. Voight, Kevin R. Woller |
2014-08-05 |
|
| 8772500 |
TRPV3 modulators |
Erol K. Bayburt, Bruce Clapham, Phil B. Cox, Jerome F. Daanen, Michael J. Dart +4 more |
2014-07-08 |
$130,605,000 |
| 8772499 |
TRPV3 modulators |
Erol K. Bayburt, Bruce Clapham, Phil B. Cox, Jerome F. Daanen, Michael J. Dart +5 more |
2014-07-08 |
$130,605,000 |
| 8609692 |
TRPV1 antagonists |
Arthur Gomtsyan, Erol K. Bayburt, Jun Chen, Stanley DiDomenico, Jerome F. Daanen +5 more |
2013-12-17 |
$84,666,000 |
| 8604053 |
TRPV1 antagonists |
Arthur Gomtsyan, Eric A. Voight, Erol K. Bayburt, Jun Chen, Jerome F. Daanen +5 more |
2013-12-10 |
$237,163,000 |
| 8338603 |
TRPV1 antagonists |
Arthur Gomtsyan, Robert G. Schmidt, Erol K. Bayburt, Jerome F. Daanen |
2012-12-25 |
|
| 8084616 |
TRPV1 antagonists |
Arthur Gomtsyan, Robert G. Schmidt, Erol K. Bayburt, Jerome F. Daanen |
2011-12-27 |
$25,258,000 |
| 7998982 |
Amide derivatives as TRPV1 antagonists |
Anil Vasudevan, Brian S. Brown, Jerome F. Daanen, Arthur Gomtsyan, Tammie K. Jinkerson +3 more |
2011-08-16 |
$18,160,000 |
| 7998993 |
TRPV1 antagonists |
Richard J. Perner, John R. Koenig, Stanley DiDomenico, Erol K. Bayburt, Jerome F. Daanen +5 more |
2011-08-16 |
$18,160,000 |
| 7115591 |
Prostaglandin endoperoxide H synthase biosynthesis inhibitors |
Lawrence A. Black, Anwer Basha, Teodozyj Kolasa, Huaqing Liu, Catherine M. McCarty +4 more |
2006-10-03 |
$46,644,000 |
| 7001895 |
Prostaglandin endoperoxide H synthase biosynthesis inhibitors |
Lawrence A. Black, Anwer Basha, Teodozyj Kolasa, Huaqing Liu, Catherine M. McCarty +4 more |
2006-02-21 |
$42,599,000 |
| 6951942 |
Glucocorticoid-selective anti-inflammatory agents |
Michael J. Coghlan, James P. Edwards, Steven W. Elmore, Todd K. Jones, Philip R. Kym +3 more |
2005-10-04 |
$145,413,000 |
| 6645968 |
Potassium channel openers |
Robert J. Altenbach, Hao Bai, Jorge D. Brioni, William A. Carroll, Murali Gopalakrishnan +8 more |
2003-11-11 |
$49,085,000 |
| 6642222 |
Pyrano, piperidino, and thiopyrano compounds and methods of use |
William A. Carroll, Konstantinos Agrios, Robert J. Altenbach, Irene Drizin |
2003-11-04 |
$89,685,000 |
| 6593335 |
Potassium channel openers |
William A. Carroll, Yiyuan Chen, Mark W. Holladay, Philip R. Kym, James P. Sullivan +4 more |
2003-07-15 |
$53,575,000 |
| 6506766 |
Glucocortiocoid-selective antinflammatory agents |
Michael J. Coghlan, James P. Edwards, Steven W. Elmore, Todd K. Jones, Philip R. Kym +3 more |
2003-01-14 |
|
